Array Biopharma, Inc. (ARRY) Tops Q2 EPS by 4c

February 4, 2013 4:46 PM EST
Get Alerts ARRY Hot Sheet
Trade ARRY Now!
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $18.4 million versus the consensus estimate of $16.52 million.

For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment